Evaluation of peptidomimetic inhibitors
Christopher Lenz, Krishna Saxena, Stefan Knapp
The paper evaluates peptidomimetic inhibitors using a set of complementary assays to support drug discovery.
bioRxiv · Dec 15, 2025 · PreprintBiochemistry
Author
Goethe University FrankfurtORCID 0000-0002-2237-5378Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Christopher Lenz, Krishna Saxena, Stefan Knapp
The paper evaluates peptidomimetic inhibitors using a set of complementary assays to support drug discovery.
bioRxiv · Dec 15, 2025 · PreprintBiochemistry
Christopher Lenz, Lewis Elson, Johannes Dopfer, Frederic Farges, Andreas Krämer, Frank Löhr, Susanne Müller, Stéphanie M. Guéret, Herbert Waldmann, Volker Dötsch, Krishna Saxena, Stefan Knapp
This study develops peptide-based tracers for SPSB2 E3 ligase by conjugating cell-penetrating peptides to degrons, enabling efficient cellular delivery and target engagement assessment.
ACS Chemical Biology · Dec 8, 2025Peer-reviewedBiochemistry
Martina Dettenhöfer, Laura Nadine Tandara, Jennifer Alisa Amrhein, Christian Georg Kurz, Martin P. Schwalm, Theresa Elisabeth Mensing, L M Wahl, Andreas Krämer, Joshua Gerninghaus, Christopher Lenz, Lewis Elson, Benedict‐Tilman Berger, Martin Schröder, Krishna Saxena, Susanne Müller, , Thomas Hanke
The paper describes the optimization of a macrocyclic scaffold to develop a selective STK10 inhibitor with nanomolar activity and good kinome selectivity.
ACS Medicinal Chemistry Letters · Oct 14, 2025Peer-reviewedBiochemistry
Martin P. Schwalm, Andreas Krämer, Anja Dölle, Janik Weckesser, Xufen Yu, Jian Jun Jin, Krishna Saxena, Stefan Knapp
This paper develops cell-based assays to monitor PROTAC degradation kinetics and ternary complex formation, revealing that ternary complex stability is critical for PROTAC efficiency.
Cell chemical biology · Jun 24, 2023Peer-reviewedMolecular Biology